Ventyx Biosciences Stock Equity Positions Weight
VTYX Stock | USD 2.61 0.17 6.12% |
Ventyx Biosciences fundamentals help investors to digest information that contributes to Ventyx Biosciences' financial success or failures. It also enables traders to predict the movement of Ventyx Stock. The fundamental analysis module provides a way to measure Ventyx Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ventyx Biosciences stock.
Ventyx | Equity Positions Weight |
Ventyx Biosciences Company Equity Positions Weight Analysis
Ventyx Biosciences' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Ventyx Equity Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for Ventyx Biosciences is extremely important. It helps to project a fair market value of Ventyx Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Ventyx Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ventyx Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ventyx Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
Competition |
According to the company disclosure, Ventyx Biosciences has an Equity Positions Weight of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Idea Optimizer Now
Idea OptimizerUse advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |
All Next | Launch Module |
Ventyx Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Ventyx Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Ventyx Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Ventyx Fundamentals
Return On Equity | -0.54 | ||||
Return On Asset | -0.33 | ||||
Current Valuation | (43.17 M) | ||||
Shares Outstanding | 70.71 M | ||||
Shares Owned By Insiders | 4.01 % | ||||
Shares Owned By Institutions | 84.93 % | ||||
Number Of Shares Shorted | 8.55 M | ||||
Price To Book | 0.79 X | ||||
EBITDA | (207.99 M) | ||||
Net Income | (192.96 M) | ||||
Cash And Equivalents | 250.45 M | ||||
Cash Per Share | 4.92 X | ||||
Total Debt | 12.51 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 14.27 X | ||||
Book Value Per Share | 3.94 X | ||||
Cash Flow From Operations | (166.52 M) | ||||
Short Ratio | 9.33 X | ||||
Earnings Per Share | (2.35) X | ||||
Target Price | 11.14 | ||||
Number Of Employees | 75 | ||||
Beta | 0.37 | ||||
Market Capitalization | 212.84 M | ||||
Total Asset | 277.69 M | ||||
Retained Earnings | (419.19 M) | ||||
Working Capital | 242.08 M | ||||
Net Asset | 277.69 M |
About Ventyx Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ventyx Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ventyx Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ventyx Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.